✔ 100% Authentic Product
👁️ Currently Viewing 491
Azobrin Plus Ophthalmic Suspension 5ml
Azobrin Plus is used in adults to manage ocular hypertension and glaucoma (increased pressure within the eyes). It is typically used in patients who are not responding well to therapy with single agents. Azobrin Plus is a combination of Brimonidine and Brinzolamide which belongs to the group of medicines called Ophthalmic anti-glaucoma agents.
Azobrin Plus is for ophthalmic use only. Instill a few drops of this medicine into the affected eye(s). Do not touch the tip of the dropper with your eye or with another body surface to avoid contamination. If you wear soft contact lenses, remove the lens before using Azobrin Plus and wait for at least 15 minutes before reinsertion.
Before using Azobrin Plus inform your doctor if you have any liver, kidney, or heart problems. You must also inform your doctor if you have low or high blood pressure, narrow-angle glaucoma, dry eyes, depression, or poor blood circulation in your body as a precaution.
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Cash on Delivery - All over Bangladesh
Regular Delivery - 8-12 Hours, Dhaka City*- Regular Delivery - 24-48 Hours, All Over Bangladesh*
✅ Description:
Relevant Products / প্রাসঙ্গিক পণ্য
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.
